Ditchcarbon
  • Customers
  1. Organizations
  2. Luminex Corporation
Public Profile
Pharmaceutical Preparation Manufacturing
US
updated 5 months ago

Luminex Corporation

Company website

Luminex Corporation, a leading player in the biotechnology industry, is headquartered in the United States. Founded in 1995, the company has established itself as a pioneer in multiplexing technology, providing innovative solutions for the life sciences and diagnostics sectors. With a strong presence in North America and expanding operations globally, Luminex focuses on developing and manufacturing a range of products, including molecular diagnostics, immunoassays, and laboratory instruments. Luminex's core offerings, such as the xMAP® Technology and the ARIES® System, are distinguished by their ability to deliver rapid, accurate results across various applications, from infectious disease testing to personalised medicine. The company has achieved significant milestones, including numerous FDA approvals and partnerships that enhance its market position. Luminex continues to drive advancements in healthcare, making it a trusted name in the biotechnology landscape.

DitchCarbon Score

How does Luminex Corporation's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

36

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

28

Industry Benchmark

Luminex Corporation's score of 36 is lower than 70% of the industry. This can give you a sense of how well the company is doing compared to its peers.

30%

Let us know if this data was useful to you

Luminex Corporation's reported carbon emissions

Inherited from DiaSorin S.p.A.

Luminex Corporation, headquartered in the US, currently does not have specific carbon emissions data available for the most recent year. The company is a current subsidiary of DiaSorin S.p.A., which may influence its climate commitments and emissions reporting. As of now, Luminex has not established any documented reduction targets or specific climate pledges. The absence of emissions data and reduction initiatives suggests that the company may be in the early stages of developing its climate strategy or may rely on the broader commitments of its parent company, DiaSorin S.p.A. Given the lack of specific emissions figures, it is essential to monitor Luminex's future disclosures for any updates on their carbon footprint and climate action plans. The company's relationship with DiaSorin S.p.A. may provide insights into potential emissions data and sustainability initiatives in the future.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

2016201820192020202120222023
Scope 1
3,223,720
0,000,000
0,000,000
0,000,000
0,000,000
0,000,000
0,000,000
Scope 2
8,426,130
00,000,000
00,000,000
0,000,000
00,000,000
00,000,000
00,000,000
Scope 3
-
-
-
-
-
-
-

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Luminex Corporation's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Luminex Corporation is in US, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Luminex Corporation is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Alere Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 13 days ago

Mesa Laboratories

US
•
Other business services (74)
Updated 4 days ago

Cepheid, Inc.

US
•
Medical, precision and optical instruments, watches and clocks (33)
Updated 13 days ago

Trinity Biotech plc

IE
•
Pharmaceutical Preparation Manufacturing
Updated 13 days ago

Genomic Health, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 13 days ago

Bio-Techne

US
•
Pharmaceutical Preparation Manufacturing
Updated 4 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v250807.8
enquiries@ditchcarbon.com+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
Verified byUL Verified
Partnered withCDP
ProductPortalDataDocumentationIntegrationsChangelogPricing
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesMethodologyBlogFAQOrganizationsIndustriesSBTI APITrust Centre
AboutTeamCareersLicense AgreementPrivacy